Stock Events

Stock Events

Search...

Ultragenyx Pharmaceutical (RARE) Q1 2025 Earnings

13FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-2.03

-1.79

-1.55

-1.31

Details

Expected EPS

-1.308481

Actual EPS

-1.39

Surprise EPS

-0.08

Surprise Percent

+6.23%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.39 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.